{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:10:07Z","timestamp":1789420207875,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI114545-05"],"award-info":[{"award-number":["5R01AI114545-05"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    CD11c\n                    <jats:sup>+<\/jats:sup>\n                    T-bet\n                    <jats:sup>+<\/jats:sup>\n                    B cells are recognized as an important component of humoral immunity and autoimmunity. These cells can be distinguished from other B cells by their higher expression of the adenosine receptor 2a. Here we address whether A\n                    <jats:sub>2A<\/jats:sub>\n                    receptor activation can affect CD11c\n                    <jats:sup>+<\/jats:sup>\n                    T-bet\n                    <jats:sup>+<\/jats:sup>\n                    B cells. We show that administration of the A\n                    <jats:sub>2A<\/jats:sub>\n                    receptor agonist CGS-21680 depletes established CD11c\n                    <jats:sup>+<\/jats:sup>\n                    T-bet\n                    <jats:sup>+<\/jats:sup>\n                    B cells in ehrlichial-infected mice, in a B cell-intrinsic manner. Agonist treatment similarly depletes CD11c\n                    <jats:sup>+<\/jats:sup>\n                    T-bet\n                    <jats:sup>+<\/jats:sup>\n                    B cells and CD138\n                    <jats:sup>+<\/jats:sup>\n                    B cells and reduces anti-nuclear antibodies in lupus-prone mice. Agonist treatment is also associated with reduced kidney pathology and lymphadenopathy. Moreover, A\n                    <jats:sub>2A<\/jats:sub>\n                    receptor stimulation depletes pathogenic lymphocytes and ameliorates disease even after disease onset, highlighting the therapeutic potential of this treatment. This study suggests that targeting the adenosine signaling pathway may provide a method for the treatment of lupus and other autoimmune diseases mediated by T-bet\n                    <jats:sup>+<\/jats:sup>\n                    B cells.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-28086-1","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T06:02:41Z","timestamp":1642744961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Adenosine receptor 2a agonists target mouse CD11c+T-bet+ B cells in infection and autoimmunity"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1992-1961","authenticated-orcid":false,"given":"Russell C.","family":"Levack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-2073","authenticated-orcid":false,"given":"Krista L.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Cabrera-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-1512","authenticated-orcid":false,"given":"Justin","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon I.","family":"Bastacky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-4299","authenticated-orcid":false,"given":"Gary M.","family":"Winslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"28086_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jvh.12659","volume":"24","author":"L-Y Chang","year":"2017","unstructured":"Chang, L.-Y., Li, Y. & Kaplan, D. E. Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells. J. Viral Hepat. 24, 389\u2013396 (2017).","journal-title":"J. Viral Hepat."},{"key":"28086_CR2","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20072683","volume":"205","author":"S Moir","year":"2008","unstructured":"Moir, S. et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 205, 1797\u20131805 (2008).","journal-title":"J. Exp. Med."},{"key":"28086_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.4049\/jimmunol.1600522","volume":"197","author":"MS Naradikian","year":"2016","unstructured":"Naradikian, M. S. et al. Cutting edge: IL-4, IL-21, and IFN-\u03b3 interact to govern T-bet and CD11c expression in TLR-activated B Cells. J. Immunol. 197, 1023\u20131028 (2016).","journal-title":"J. Immunol."},{"key":"28086_CR4","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.4049\/jimmunol.0901297","volume":"183","author":"GE Weiss","year":"2009","unstructured":"Weiss, G. E. et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 183, 2176\u20132182 (2009).","journal-title":"J. Immunol."},{"key":"28086_CR5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4049\/jimmunol.2000206","volume":"205","author":"RC Levack","year":"2020","unstructured":"Levack, R. C., Newell, K. L., Popescu, M., Cabrera-Martinez, B. & Winslow, G. M. CD11c+ T-bet+ B Cells Require IL-21 and IFN-\u03b3 from Type 1 T Follicular helper cells and intrinsic Bcl-6 expression but develop normally in the absence of T-bet. J. Immunol. 205, 1050\u20131058 (2020).","journal-title":"J. Immunol."},{"key":"28086_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cellimm.2017.09.004","volume":"321","author":"A Myles","year":"2017","unstructured":"Myles, A., Gearhart, P. J. & Cancro, M. P. Signals that drive T-bet expression in B cells. Cell. Immunol. 321, 3\u20137 (2017).","journal-title":"Cell. Immunol."},{"key":"28086_CR7","doi-asserted-by":"publisher","first-page":"e1006576","DOI":"10.1371\/journal.ppat.1006576","volume":"13","author":"N Obeng-Adjei","year":"2017","unstructured":"Obeng-Adjei, N. et al. Malaria-induced interferon-gamma drives the expansion of Tbethi atypical memory B cells. PLoS Pathog. 13, e1006576 (2017).","journal-title":"PLoS Pathog."},{"key":"28086_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun 9, 1758 (2018).","journal-title":"Nat Commun"},{"key":"28086_CR9","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.celrep.2018.06.074","volume":"24","author":"KJ Kenderes","year":"2018","unstructured":"Kenderes, K. J. et al. T-bet + IgM memory cells generate multi-lineage effector B cells. Cell Rep. 24, 824\u2013837 e3 (2018).","journal-title":"Cell Rep."},{"key":"28086_CR10","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.4049\/jimmunol.1300062","volume":"191","author":"JL Yates","year":"2013","unstructured":"Yates, J. L., Racine, R., McBride, K. M. & Winslow, G. M. T cell-dependent IgM memory B cells generated during bacterial infection are required for IgG responses to antigen challenge. J. Immunol. 191, 1240\u20131249 (2013).","journal-title":"J. Immunol."},{"key":"28086_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26677-x","volume":"8","author":"S Changrob","year":"2018","unstructured":"Changrob, S. et al. Persistence of long-lived memory B cells specific to Duffy binding protein in individuals exposed to Plasmodium vivax. Sci. Rep. 8, 8347 (2018).","journal-title":"Sci. Rep."},{"key":"28086_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fimmu.2019.00559","volume":"10","author":"A Ly","year":"2019","unstructured":"Ly, A. & Hansen, D. S. Development of B cell memory in Malaria. Front. Immunol. 10, 559 (2019).","journal-title":"Front. Immunol."},{"key":"28086_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.20121970","volume":"210","author":"MF Muellenbeck","year":"2013","unstructured":"Muellenbeck, M. F. et al. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 210, 389\u2013399 (2013).","journal-title":"J. Exp. Med."},{"key":"28086_CR14","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/art.37828","volume":"65","author":"D Saadoun","year":"2013","unstructured":"Saadoun, D. et al. Expansion of autoreactive unresponsive CD21-\/low B cells in Sj\u00f6gren\u2019s syndrome associated lymphoproliferation. Arthritis Rheum. 65, 1085\u20131096 (2013).","journal-title":"Arthritis Rheum."},{"key":"28086_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","volume":"113","author":"C Wehr","year":"2004","unstructured":"Wehr, C. et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113, 161\u2013171 (2004).","journal-title":"Clin. Immunol."},{"key":"28086_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 e6 (2018).","journal-title":"Immunity"},{"key":"28086_CR17","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1073\/pnas.0901984106","volume":"106","author":"M Rakhmanov","year":"2009","unstructured":"Rakhmanov, M. et al. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. USA 106, 13451\u201313456 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR18","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110\u20132121 (2011).","journal-title":"N. Engl. J. Med."},{"key":"28086_CR19","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.1002\/art.20592","volume":"50","author":"JH Anolik","year":"2004","unstructured":"Anolik, J. H. et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis & Rheum. 50, 3580\u20133590 (2004).","journal-title":"Arthritis & Rheum."},{"key":"28086_CR20","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1073\/pnas.1001074107","volume":"107","author":"H Huang","year":"2010","unstructured":"Huang, H., Benoist, C. & Mathis, D. Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc. Natl. Acad. Sci. USA 107, 4658\u20134663 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR21","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178, 6624\u20136633 (2007).","journal-title":"J. Immunol."},{"key":"28086_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.imbio.2008.10.004","volume":"214","author":"O Wu","year":"2009","unstructured":"Wu, O. et al. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Immunobiology 214, 392\u2013402 (2009).","journal-title":"Immunobiology"},{"key":"28086_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fmed.2020.00085","volume":"7","author":"X You","year":"2020","unstructured":"You, X. et al. Double negative B cell is associated with renal impairment in systemic lupus erythematosus and acts as a marker for nephritis remission. Front. Med. (Lausanne) 7, 85 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"28086_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13075-017-1438-2","volume":"19","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. T-bet(+)CD11c(+) B cells are critical for antichromatin immunoglobulin G production in the development of lupus. Arthritis Res. Ther. 19, 225 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"28086_CR25","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1182\/blood-2011-01-331462","volume":"118","author":"AV Rubtsov","year":"2011","unstructured":"Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)\u2013driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305\u20131315 (2011).","journal-title":"Blood"},{"key":"28086_CR26","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1172\/JCI91250","volume":"127","author":"K Rubtsova","year":"2017","unstructured":"Rubtsova, K. et al. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J. Clin. Invest. 127, 1392\u20131404 (2017).","journal-title":"J. Clin. Invest."},{"key":"28086_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.immuni.2019.04.004","volume":"50","author":"SL Stone","year":"2019","unstructured":"Stone, S. L. et al. T-bet transcription factor promotes antibody-secreting cell differentiation by limiting the inflammatory effects of IFN-gamma on B cells. Immunity 50, 1172\u20131187 e7 (2019).","journal-title":"Immunity"},{"key":"28086_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4049\/jimmunol.1500055","volume":"195","author":"AV Rubtsov","year":"2015","unstructured":"Rubtsov, A. V. et al. CD11c-expressing B cells are located at the T Cell\/B cell border in spleen and are potent APCs. J. Immunol 195, 71\u201379 (2015).","journal-title":"J. Immunol"},{"key":"28086_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/eji.201545760","volume":"46","author":"P Blanco","year":"2016","unstructured":"Blanco, P., Ueno, H. & Schmitt, N. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. European J. Immunol. 46, 281\u2013290 (2016).","journal-title":"European J. Immunol."},{"key":"28086_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1172\/jci.insight.130062","volume":"4","author":"AV Bocharnikov","year":"2019","unstructured":"Bocharnikov, A. V. et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight 4, 85 (2019).","journal-title":"JCI Insight"},{"key":"28086_CR31","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.25032","volume":"62","author":"N Simpson","year":"2010","unstructured":"Simpson, N. et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 62, 234\u2013244 (2010).","journal-title":"Arthritis Rheum."},{"key":"28086_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cellimm.2017.07.006","volume":"321","author":"GM Winslow","year":"2017","unstructured":"Winslow, G. M., Papillion, A. M., Kenderes, K. J. & Levack, R. C. CD11c+ T-bet+ memory B cells: immune maintenance during chronic infection and inflammation? Cell. Immunol. 321, 8\u201317 (2017).","journal-title":"Cell. Immunol."},{"key":"28086_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nri.2016.4","volume":"16","author":"C Cekic","year":"2016","unstructured":"Cekic, C. & Linden, J. Purinergic regulation of the immune system. Nat. Rev. Immunol. 16, 177 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"28086_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein, B. N. & Sitkovsky, M. Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat. Rev. Rheumatol. 13, 41\u201351 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"28086_CR35","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta, A. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA 103, 13132\u201313137 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin, G. G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta. 1783, 673\u2013694 (2008).","journal-title":"Biochim. Biophys. Acta."},{"key":"28086_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4049\/jimmunol.1500591","volume":"195","author":"F Morandi","year":"2015","unstructured":"Morandi, F. et al. CD56brightCD16\u2212 NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation. J. Immunol. 195, 965\u2013972 (2015).","journal-title":"J. Immunol."},{"key":"28086_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fimmu.2012.00190","volume":"3","author":"A Ohta","year":"2012","unstructured":"Ohta, A. The development and immunosuppressive functions of CD4+CD25+FoxP3+ regulatory T cells are under influence of the adenosine- A2A adenosine receptor pathway. Front. Immunol. 3, 190 (2012).","journal-title":"Front. Immunol."},{"key":"28086_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.1601686","volume":"198","author":"SE Schmiel","year":"2017","unstructured":"Schmiel, S. E., Yang, J. A., Jenkins, M. K. & Mueller, D. L. Cutting edge: adenosine A2a receptor signals inhibit germinal center T follicular helper cell differentiation during the primary response to vaccination. J. Immunol. 198, 623\u2013628 (2017).","journal-title":"J. Immunol."},{"key":"28086_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/art.40796","volume":"71","author":"SE Schmiel","year":"2019","unstructured":"Schmiel, S. E. et al. Adenosine 2a receptor signal blockade of murine autoimmune arthritis via inhibition of pathogenic germinal center\u2013follicular helper T cells. Arthritis Rheumatol. 71, 773\u2013783 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"28086_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0360-8","volume":"6","author":"RD Leone","year":"2018","unstructured":"Leone, R. D. & Emens, L. A. Targeting adenosine for cancer immunotherapy. J. Immunother. Cancer 6, 57 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"28086_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.csbj.2015.03.008","volume":"13","author":"RD Leone","year":"2015","unstructured":"Leone, R. D., Lo, Y. C. & Powell, J. D. A2aR antagonists: next generation checkpoint blockade for cancer immunotherapy. Comput. Struct. Biotechnol. J. 13, 265\u2013272 (2015).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"28086_CR43","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1172\/JCI45559","volume":"121","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J. Clin. Invest. 121, 2371\u20132382 (2011).","journal-title":"J. Clin. Invest."},{"key":"28086_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","volume":"111","author":"PE Zarek","year":"2008","unstructured":"Zarek, P. E. et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251\u2013259 (2008).","journal-title":"Blood"},{"key":"28086_CR45","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.1073\/pnas.0711175105","volume":"105","author":"JH Mills","year":"2008","unstructured":"Mills, J. H. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105, 9325\u20139330 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR46","doi-asserted-by":"publisher","first-page":"4617464","DOI":"10.1155\/2019\/4617464","volume":"2019","author":"ZH Du","year":"2019","unstructured":"Du, Z. H. et al. Adenosine A2A receptor mediates inhibition of synovitis and osteoclastogenesis after electroacupuncture in rats with collagen-induced arthritis. Evid. Based. Complement Alternat. Med. 2019, 4617464 (2019).","journal-title":"Evid. Based. Complement Alternat. Med."},{"key":"28086_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/ijms18040697","volume":"18","author":"A Ravani","year":"2017","unstructured":"Ravani, A. et al. Role and function of A2A and A(3) adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis. Int. J. Mol. Sci. 18, 697 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"28086_CR48","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1186\/ar3527","volume":"13","author":"K Varani","year":"2011","unstructured":"Varani, K. et al. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release. Arthritis Res. Ther. 13, R197 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"28086_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1177\/0961203310393262","volume":"20","author":"L Zhang","year":"2011","unstructured":"Zhang, L. Adenosine 2A receptor is protective against renal injury in MRL\/lpr mice. Lupus 20, 667\u2013677 (2011).","journal-title":"Lupus"},{"key":"28086_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13075-016-1089-8","volume":"18","author":"A Bortoluzzi","year":"2016","unstructured":"Bortoluzzi, A. et al. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Res. Ther. 18, 192 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"28086_CR51","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4049\/jimmunol.1500792","volume":"195","author":"JR Giles","year":"2015","unstructured":"Giles, J. R., Kashgarian, M., Koni, P. A. & Shlomchik, M. J. B Cell\u2013Specific MHC Class II deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus. J. Immunol. 195, 2571\u20132579 (2015).","journal-title":"J. Immunol."},{"key":"28086_CR52","doi-asserted-by":"publisher","first-page":"e000199","DOI":"10.1136\/lupus-2016-000199","volume":"5","author":"ML Richard","year":"2018","unstructured":"Richard, M. L. & Gilkeson, G. Mouse models of lupus: what they tell us and what they don\u2019t. Lupus Sci. Med. 5, e000199 (2018).","journal-title":"Lupus Sci. Med."},{"key":"28086_CR53","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1073\/pnas.97.12.6670","volume":"97","author":"L Morel","year":"2000","unstructured":"Morel, L. et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97, 6670\u20136675 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR54","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1073\/pnas.082114899","volume":"99","author":"SL Peng","year":"2002","unstructured":"Peng, S. L., Szabo, S. J. & Glimcher, L. H. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99, 5545\u20135550 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.intimp.2019.04.037","volume":"72","author":"NJ Geraghty","year":"2019","unstructured":"Geraghty, N. J., Adhikary, S. R., Watson, D. & Sluyter, R. The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease. Int. Immunopharmacol. 72, 479\u2013486 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"28086_CR56","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1186\/ar1009","volume":"5","author":"AC Grammer","year":"2003","unstructured":"Grammer, A. C. & Lipsky, P. E. B cell abnormalities in systemic lupus erythematosus. Arthritis Res. Ther. 5, S22 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"28086_CR57","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1056\/NEJM198806023182203","volume":"318","author":"WJ McCune","year":"1988","unstructured":"McCune, W. J. et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N. Engl. J. Med. 318, 1423\u20131431 (1988).","journal-title":"N. Engl. J. Med."},{"key":"28086_CR58","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.4049\/jimmunol.1502448","volume":"197","author":"N Claes","year":"2016","unstructured":"Claes, N. et al. Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients. J. Immunol. 197, 4576\u20134583 (2016).","journal-title":"J. Immunol."},{"key":"28086_CR59","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.humimm.2008.09.008","volume":"69","author":"G Frisullo","year":"2008","unstructured":"Frisullo, G. et al. Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease. Hum. Immunol. 69, 837\u2013839 (2008).","journal-title":"Hum. Immunol."},{"key":"28086_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.25508","volume":"86","author":"J van Langelaar","year":"2019","unstructured":"van Langelaar, J. et al. Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis. Ann Neurol 86, 264\u2013278 (2019).","journal-title":"Ann Neurol"},{"key":"28086_CR61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","volume":"11","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar, J., Rijvers, L., Smolders, J. & van Luijn, M. M. B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers. Front. Immunol. 11, 760 (2020).","journal-title":"Front. Immunol."},{"key":"28086_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","volume":"11","author":"MW Alnouri","year":"2015","unstructured":"Alnouri, M. W. et al. Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal. 11, 389\u2013407 (2015).","journal-title":"Purinergic Signal."},{"key":"28086_CR63","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1073\/pnas.1308209110","volume":"110","author":"PA Beavis","year":"2013","unstructured":"Beavis, P. A. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors. Proc. Natl. Acad. Sci. USA 110, 14711\u201314716 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"28086_CR64","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta, A. & Sitkovsky, M. Extracellular adenosine-mediated modulation of regulatory T cells. Front. Immunol. 5, 304 (2014).","journal-title":"Front. Immunol."},{"key":"28086_CR65","doi-asserted-by":"publisher","first-page":"C530","DOI":"10.1152\/ajpcell.00385.2010","volume":"301","author":"M Romio","year":"2011","unstructured":"Romio, M. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am. J. Physiol. Cell Physiol. 301, C530\u2013C539 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"28086_CR66","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2019-215039","volume":"78","author":"C Wu","year":"2019","unstructured":"Wu, C. et al. Lupus-associated atypical memory B cells are mTORC1-hyperactivated and functionally dysregulated. Ann. Rheum. Dis. 78, 1090\u20131100 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"28086_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2019.00162","volume":"10","author":"C Sorrentino","year":"2019","unstructured":"Sorrentino, C. et al. Adenosine A2A receptor stimulation inhibits TCR-induced Notch1 Activation in CD8+T-Cells. Front. Immunol. 10, 162 (2019).","journal-title":"Front. Immunol."},{"key":"28086_CR68","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1084\/jem.20130249","volume":"210","author":"C Cekic","year":"2013","unstructured":"Cekic, C., Sag, D., Day, Y. J. & Linden, J. Extracellular adenosine regulates naive T cell development and peripheral maintenance. J. Exp. Med. 210, 2693\u20132706 (2013).","journal-title":"J. Exp. Med."},{"key":"28086_CR69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/eji.200425524","volume":"35","author":"S Minguet","year":"2005","unstructured":"Minguet, S. et al. Adenosine and cAMP are potent inhibitors of the NF-\u03baB pathway downstream of immunoreceptors. Eur. J. Immunol. 35, 31\u201341 (2005).","journal-title":"Eur. J. Immunol."},{"key":"28086_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<71::AID-JCP8>3.0.CO;2-N","volume":"180","author":"JH Myklebust","year":"1999","unstructured":"Myklebust, J. H. et al. Activation of the CAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J. Cellular Physiol. 180, 71\u201380 (1999).","journal-title":"J. Cellular Physiol."},{"key":"28086_CR71","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1126\/science.1191793","volume":"330","author":"I Vikstrom","year":"2010","unstructured":"Vikstrom, I. et al. Mcl-1 is essential for germinal center formation and B cell memory. Science 330, 1095\u20131099 (2010).","journal-title":"Science"},{"key":"28086_CR72","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/ni.2527","volume":"14","author":"V Peperzak","year":"2013","unstructured":"Peperzak, V. et al. Mcl-1 is essential for the survival of plasma cells. Nat. Immunol. 14, 290\u2013297 (2013).","journal-title":"Nat. Immunol."},{"key":"28086_CR73","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.febslet.2010.05.061","volume":"584","author":"LW Thomas","year":"2010","unstructured":"Thomas, L. W., Lam, C. & Edwards, S. W. Mcl-1; the molecular regulation of protein function. FEBS Lett. 584, 2981\u20132989 (2010).","journal-title":"FEBS Lett."},{"key":"28086_CR74","doi-asserted-by":"publisher","first-page":"e92009","DOI":"10.1371\/journal.pone.0092009","volume":"9","author":"LJ Conter","year":"2014","unstructured":"Conter, L. J., Song, E., Shlomchik, M. J. & Tomayko, M. M. CD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence. PLoS One 9, e92009 (2014).","journal-title":"PLoS One"},{"key":"28086_CR75","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JCW Edwards","year":"2004","unstructured":"Edwards, J. C. W. et al. Efficacy of B-cell\u2013targeted therapy with rituximab in patients with rheumatoid arthritis. New Engl. J. Med. 350, 2572\u20132581 (2004).","journal-title":"New Engl. J. Med."},{"key":"28086_CR76","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser, S. L. et al. B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis. N. Engl. J. Med. 358, 676\u2013688 (2008).","journal-title":"N. Engl. J. Med."},{"key":"28086_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrrheum.2009.100","volume":"5","author":"I Sanz","year":"2009","unstructured":"Sanz, I. The conundrum of B cell depletion in SLE. Nat. Rev. Rheumatol. 5, 304\u2013305 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"28086_CR78","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","volume":"9","author":"K Hofmann","year":"2018","unstructured":"Hofmann, K., Clauder, A.-K. & Manz, R. A. Targeting B cells and plasma cells in autoimmune diseases. Front. Immunol. 9, 835 (2018).","journal-title":"Front. Immunol."},{"key":"28086_CR79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1756285612474333","volume":"6","author":"K Lehmann-Horn","year":"2013","unstructured":"Lehmann-Horn, K., Kronsbein, H. C. & Weber, M. S. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther. Adv. Neurol. Disord. 6, 161\u2013173 (2013).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"28086_CR80","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","volume":"14","author":"AE Iskandrian","year":"2007","unstructured":"Iskandrian, A. E. et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J. Nucl. Cardiol. 14, 645\u2013658 (2007).","journal-title":"J. Nucl. Cardiol."},{"key":"28086_CR81","doi-asserted-by":"publisher","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","volume":"31","author":"AJ Carman","year":"2011","unstructured":"Carman, A. J., Mills, J. H., Krenz, A., Kim, D.-G. & Bynoe, M. S. Adenosine receptor signaling modulates permeability of the blood-brain barrier. J. Neurosci. 31, 13272\u201313280 (2011).","journal-title":"J. Neurosci."},{"key":"28086_CR82","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/IAI.00705-07","volume":"75","author":"C Bitsaktsis","year":"2007","unstructured":"Bitsaktsis, C., Nandi, B., Racine, R., MacNamara, K. C. & Winslow, G. T-cell-independent humoral immunity is sufficient for protection against fatal intracellular Ehrlichia infection. Infect. Immun. 75, 4933\u20134941 (2007).","journal-title":"Infect. Immun."},{"key":"28086_CR83","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1172\/JCI132328","volume":"130","author":"JS Tilstra","year":"2020","unstructured":"Tilstra, J. S. et al. B cell\u2013intrinsic TLR9 expression is protective in murine lupus. J. Clin. Invest. 130, 3172\u20133187 (2020).","journal-title":"J. Clin. Invest."},{"key":"28086_CR84","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2249.1991.tb05775.x","volume":"86","author":"F Blanco","year":"1991","unstructured":"Blanco, F., Kalsi, J. & Isenberg, D. A. Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases. Clin. Exp. Immunol. 86, 66 (1991).","journal-title":"Clin. Exp. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28086-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T10:54:53Z","timestamp":1669287293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28086"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28086-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"24 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: G.M.W. and R.C.L. are inventors listed on a patent pending for the use of A<sub>2A<\/sub> receptor agonists in the therapeutic depletion of CD11c<sup>+<\/sup>T-bet<sup>+<\/sup> B cells in diseases mediated by these B cells. Applicant: SUNY Research Foundation, Application Serial Number: PCT\/US2019\/045624. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}